This notice has been superseded. See the latest notice: Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) (Solicitation)
SolicitationActiveARPA-H-SOL-26-163
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / NATIONAL INSTITUTES OF HEALTH / ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Key dates?
- Posted?
- Oct 29, 2026
- Response deadline?
- Dec 2, 2026, 8:00 PM UTC
- Archive date?
- Jan 19, 2027
- Archive type?
- autocustom
Classification?
- Notice type?
- Solicitation
- Base type?
- Solicitation
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- AN13
NAICS?
Issuing office?
- Department?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-tier?
- NATIONAL INSTITUTES OF HEALTH
- Office?
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
- Office code?
- 075.7529.75N992
- Organization type?
- OFFICE
- Office address?
- Washington, DC, 20005, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- —
- State?
- —
- Zip?
- —
- Country?
- UNITED STATES
Contacts?
- SPECTRA Teamprimary
Description?
Amendment 2 (10/29/2026): Numerous changes including, but not limited to,: ISO updates in Parts I, II, III and VI; TA1 clarifications; TA2 updates; TA4 updates; Q&A link added Provides Attachment B1 for TA4 Proposal Requirements and Proposal Volume Templates. Provides Attachment A2 for TA1 Solution Summary Requirements and Attachment A3 for TA2 Solution Summary Requirements. Amendment 1 (10/14/2026): Update due dates and/or times of all TAs SPECTRA will identify and act on autism trajectories, the evolving developmental paths individuals follow across the lifespan from the prenatal period through aging, spanning autism characteristics, co-occurring conditions, and functional outcomes together with the genetic, biological, behavioral, iatrogenic (medical influences), environmental factors and their nonlinear interactions. Rather than examining these factors in isolation, SPECTRA will examine how they combine and interact, including their nonlinear interactions, to produce autism and its co-occurring conditions over time. SPECTRA will also develop technologies that serve two purposes at once: extending reliable assessment beyond the clinic while improving everyday communication, function, and quality of life. The same tools people use to live more fully will also generate the data that drive measurement and personalized care.
Attachments (5)?
- Download📎 SPECTRA_ATTACHMENT+A2_TA1+Solution+Summary+Format+and+Instructions.pdfapplication/pdf · 213 KB
- Download📎 SPECTRA+ISO+ARPA-H-SOL-26-163+Amendment+2.pdfapplication/pdf · 697 KB
- Download📎 SPECTRA_TA4_Proposal+Templates.zipapplication/octet-stream · 1.2 MB
- Download📎 SPECTRA_ATTACHMENT+A3_TA2+Solution+Summary+Format+and+Instructions.pdfapplication/pdf · 231 KB
- Download📎 SPECTRA_ATTACHMENT+B1_TA4+Proposal+Requirements.pdfapplication/pdf · 305 KB
Other notices in this solicitation?
- SolicitationSystems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)Nov 9, 2026LATEST
- SolicitationSystems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)Nov 9, 2026LATEST
- SolicitationSystems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)Oct 14, 2026
- SolicitationSystems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)Sep 17, 2026
Similar open contracts
Metadata?
- Notice ID?
- 9405fd60435a4823bc2dcec68a13e53e
- Full path?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
- Office code?
- 075.7529.75N992
- Ingested?
- Oct 30, 2026
- Updated?
- Nov 11, 2026